Page results
-
This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing
-
This is information for women who have been given a diagnosis of adenomyosis.
-
This service provides a tertiary level, second opinion service, specialising in the diagnostic assessment and treatment of complex speech sound disorders. The team has particular expertise in Childhood Apraxia of Speech (CAS).
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
-
Bones marrow harvest patient information page.
-
Information about the Integrative Talking Therapies service at the Royal London Hospital for Integrated Medicine.
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
This page provides information about ERCP (Endoscopic Retrograde Cholangiopancreatography) procedure.
-
The Neuroimmunology and CSF Laboratory at the Institute of Neurology, UCLH is a UKAS accredited medical laboratory No. 8045.
File results
-
FOI/2022/0300 - EPRR Coordination of emergency/disaster management activities
-
FOI/2022/0302 - Treatment with conditions for rheumatology/ dermatology
-
FOI/2022/0304 - Histopathology labs that run immunohistochemistry diagnostic testing
-
FOI/2022/0305 - Ethnic minority categories used for Gypsy, Roma, Traveller groups
-
FOI/2022/0306 - Policy and associates procedure using robotics
-
FOI/2022/0309 - In-patient deaths
-
FOI/2022/0314 - Use of herbicide containing glyphosate on hospital grounds
-
FOI/2022/0315 - Role of patient safety specialists within the Trust
-
FOI/2022/0317 - Inpatient mental health facilities
-
FOI/2022/0318 - HIMMS Electronic Medical Record Adoption Model (EMRAM) level achieved at Trust